These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9661905)
1. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Oyama T; Kashiwabara K; Yoshimoto K; Arnold A; Koerner F Cancer Res; 1998 Jul; 58(13):2876-80. PubMed ID: 9661905 [TBL] [Abstract][Full Text] [Related]
2. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters. Naidu R; Wahab NA; Yadav MM; Kutty MK Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618 [TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Zukerberg LR; Yang WI; Gadd M; Thor AD; Koerner FC; Schmidt EV; Arnold A Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778 [TBL] [Abstract][Full Text] [Related]
4. Deregulated expression of p27(Kip1) in human breast cancers. Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577 [TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast. Geradts J; Ingram CD Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034 [TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct. Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677 [TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma. Zhu XL; Hartwick W; Rohan T; Kandel R Mod Pathol; 1998 Nov; 11(11):1082-8. PubMed ID: 9831206 [TBL] [Abstract][Full Text] [Related]
8. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection]. Mrhalová M; Kodet R; Strnad P Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908 [TBL] [Abstract][Full Text] [Related]
9. p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma. Rey MJ; Fernández PL; Jares P; Muñoz M; Nadal A; Peiró N; Nayach I; Mallofré C; Muntané J; Campo E; Estapé J; Cardesa A J Pathol; 1998 Mar; 184(3):265-71. PubMed ID: 9614378 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. Wong SC; Chan JK; Lee KC; Hsiao WL J Pathol; 2001 May; 194(1):35-42. PubMed ID: 11329139 [TBL] [Abstract][Full Text] [Related]
11. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53. Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265 [TBL] [Abstract][Full Text] [Related]
12. Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma. Prasad R; Boland GP; Cramer A; Anderson E; Knox WF; Bundred NJ Cancer; 2003 Dec; 98(12):2539-46. PubMed ID: 14669271 [TBL] [Abstract][Full Text] [Related]
13. Localization and expression of p27KIP1 in multistage colorectal carcinogenesis. Ciaparrone M; Yamamoto H; Yao Y; Sgambato A; Cattoretti G; Tomita N; Monden T; Rotterdam H; Weinstein IB Cancer Res; 1998 Jan; 58(1):114-22. PubMed ID: 9426067 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast. Vos CB; Ter Haar NT; Peterse JL; Cornelisse CJ; van de Vijver MJ J Pathol; 1999 Feb; 187(3):279-84. PubMed ID: 10398079 [TBL] [Abstract][Full Text] [Related]
15. Decreased p27(Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma. Hui AM; Cui X; Makuuchi M; Li X; Shi YZ; Takayama T Hepatology; 1999 Nov; 30(5):1167-73. PubMed ID: 10534337 [TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Alle KM; Henshall SM; Field AS; Sutherland RL Clin Cancer Res; 1998 Apr; 4(4):847-54. PubMed ID: 9563877 [TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human breast carcinoma. Sasano H; Frost AR; Saitoh R; Taniyama Y; Nagura H; Matsunaga G; Takehana K; Kimura M; Silverberg SG Anticancer Res; 1997; 17(5A):3685-90. PubMed ID: 9413224 [TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644 [TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. Gillett CE; Lee AH; Millis RR; Barnes DM J Pathol; 1998 Apr; 184(4):396-400. PubMed ID: 9664905 [TBL] [Abstract][Full Text] [Related]
20. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade. Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]